Carlsmed, Inc. Operating Expenses
Carlsmed, Inc. (CARL) reported Operating Expenses of $25.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- Carlsmed, Inc. operating expenses for the quarter ending 2026-06-30 was $25.58M, a 66.40% increase year-over-year.
- Carlsmed, Inc. operating expenses for the quarter ending 2026-03-31 was $21.70M, a 62.49% increase year-over-year.
- Carlsmed, Inc. operating expenses for the quarter ending 2025-12-31 was $20.93M, a 78.53% increase year-over-year.
- Carlsmed, Inc. operating expenses for the quarter ending 2025-09-30 was $18.96M, a 50.79% increase year-over-year.
- Carlsmed, Inc. operating expenses for fiscal 2025 was $68.61M, a 55.34% increase from fiscal 2024.
- Carlsmed, Inc. operating expenses for fiscal 2024 was $44.17M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.58M 10-Q · filed 2026-08-05 | $47.28M 10-Q · filed 2026-08-05 | $68.20M derived: sum of 3 quarters · filed 2026-08-05 | $87.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $21.70M 10-Q · filed 2026-05-05 | $42.63M derived: sum of 2 quarters · filed 2026-05-05 | $61.59M derived: sum of 3 quarters · filed 2026-05-05 | $76.96M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $20.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $39.89M derived: sum of 2 quarters · filed 2026-02-25 | $55.26M derived: sum of 3 quarters · filed 2026-08-05 | $68.61M 10-K · filed 2026-02-25 |
| 2025-09-30 | $18.96M 10-Q · filed 2025-11-06 | $34.33M derived: sum of 2 quarters · filed 2026-08-05 | $47.69M 10-Q · filed 2025-11-06 | $59.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $15.37M 10-Q · filed 2026-08-05 | $28.73M 10-Q · filed 2026-08-05 | $40.45M derived: sum of 3 quarters · filed 2026-08-05 | $53.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $13.36M 10-Q · filed 2026-05-05 | $25.08M derived: sum of 2 quarters · filed 2026-05-05 | $37.65M derived: sum of 3 quarters · filed 2026-05-05 | $48.53M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $11.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $24.30M derived: sum of 2 quarters · filed 2026-02-25 | $35.18M derived: sum of 3 quarters · filed 2026-02-25 | $44.17M 10-K · filed 2026-02-25 |
| 2024-09-30 | $12.57M 10-Q · filed 2025-11-06 | $23.46M derived: sum of 2 quarters · filed 2025-11-06 | $32.45M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $10.88M 10-Q · filed 2025-08-28 | $19.87M 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |